IM Cannabis (IMCC) Change in Accured Expenses (2020 - 2026)

IM Cannabis' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$1.4 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 135.09% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$6.1 million (down 867.35% YoY), while the FY2024 annual figure was -$5.2 million, down 839.09% from the prior year.
• Change in Accured Expenses was -$1.4 million for Q1 2026 at IM Cannabis, up from -$1.8 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $11.4 million in Q4 2022 to a low of -$6.8 million in Q4 2024.
• Historically, Change in Accured Expenses has averaged $260141.6 across 5 years, with a median of -$345000.8 in 2022.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses slumped 19571.21% in 2024, then soared 289.67% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at $11.4 million in 2022, then plunged by 106.55% to -$745553.6 in 2023, then sank by 818.58% to -$6.8 million in 2024, then surged by 73.98% to -$1.8 million in 2025, then increased by 23.92% to -$1.4 million in 2026.
• The last three Change in Accured Expenses figures came in at -$1.4 million (Q1 2026), -$1.8 million (Q2 2025), and $3.9 million (Q1 2025), per Business Quant data.